Stephen M. Dow

Citrix Systems, Inc. is an enterprise software company. It engages in the business of delivering a digital workspace solution that provides unified, reliable, and secure access to work resources and simplifies work execution and collaboration across every work channel, device, and location. The company was founded by Edward E. Iacobucci on April 17, 1989 and is headquartered in Fort Lauderdale, FL.

Airgo Networks, Inc. develops wireless technology products. They design and produce chipsets for network management. They offer chipsets, product designs, and software that enable mainstream adoption and new applications by greatly increasing the range, speed, reliability, security, and ease-of-use of WLAN systems. The company was founded in January, 2001 by Greg Raleigh and is headquartered in Palo Alto, CA.

ProactiveNet, Inc. provides business service management software solutions. The company offers real-time applications, SLA and infrastructure performance analytics. It monitors, identifies, diagnoses and resolves performance problems for web and client/server applications. ProactiveNet was founded in 1997 and is headquartered in Santa Clara, CA.

GreenBorder Technologies, Inc. was developed software solutions. The company was founded in 2001 and was headquartered in Mountain View, CA.

Kabira Technologies provides communications service providers software applications and performance technology elements that accelerate their Pace of Return by reducing time-to-revenue while lowering overall cost of growth. With installations serving over 700 million subscribers for over 100 customers in more than 40 countries, Kabira has established its reputation for delivering highly scalable and highly reliable solutions. Based on Fluency™, Kabira's powerful transaction platform, Kabira's Policy, Fulfillment and Payments Orchestration product suites are designed to provide essential capabilities that enable service providers to launch services in record time, while creating new ways to monetize their investments. Some of Kabira's customers include AT&T Corp., Orange/France Telecom, Visa, VimpelCom, T-Mobile, Hutchison, Saudi Telecom and NTT. Kabira, Orchestration by Kabira, Policy Orchestration, Fulfillment Orchestration, Payments Orchestration, Fluency, Fluency at the Core and the Kabira logo are registered trademarks, registered service marks or trademarks or service marks of Kabira, and its affiliates, in the United States and certain other countries. All other trademarks are the property of their respective owners.

Reactive NanoTechnologies, Inc. develops and manufactures nanofoil technologies for reaction initiation and joining applications. Its products are used in armor mounting, structural joining, component mounting, sealing, sputtering targets joining, and thermal interface material applications. The firm offers services to the energetics, semiconductor, and military aerospace industries. The company was founded in 2001 and is headquartered in Hunt Valley, MD.

Limerick BioPharma is dedicated to the discovery and development of novel small molecule product candidates to address areas of significant unmet medical need. Their intent is to bring forth innovative therapies that have the potential to change treatment paradigms via their enhanced safety and / or efficacy profiles. Limerick is developing novel products that can enhance the safety of existing therapeutic agents or function as innovative stand-alone therapies. Their lead programs are in the areas of metabolic diseases and solid organ transplantation. In metabolic diseases, their programs are in clinical development for treatment of diabetes and dyslipidemia. For transplant indications, their programs are in clinical development as adjunctive therapy to treat metabolic dysregulation induced by leading immunosuppressants. Beyond these first-generation programs, Limerick has developed a proprietary and cutting-edge discovery platform that can be leveraged for other high-need, high-value areas. They intend to maximize the value of their product candidates and discovery platform through independent development, licensing and other partnership opportunities.

Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.